| abstract |
The invention provides novel anti- atherosclerotic compounds of the type where A is the residue of a long chain, unsaturated fatty acid or cyclopropano analogues thereof; the -CO-N< moiety forms an amide or hydrazide group or the N atom may be part of a 4-optionally-substituted-styryl- hexahydro-4-indolinol-(1) group. The compounds are made by acylation of amines. |